Y. Chen, C. Hu, and Y. Wang. Biostatistics (Oxford, England), 7 (4):
515-29(October 2006)5077<m:linebreak></m:linebreak>JID: 100897327; 2006/02/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
H. Gardarsdottir, E. Heerdink, and A. Egberts. Pharmacoepidemiology and drug safety, 15 (5):
338-43(May 2006)4368<br/>PUBM: Print; JID: 9208369; 0 (Antidepressive Agents); ppublish;<br/>Mesures de freqüència.
H. Janes, L. Sheppard, and K. Shepherd. Annals of epidemiology, 18 (10):
792-802(October 2008)4973<m:linebreak></m:linebreak>JID: 9100013; 0 (Air Pollutants); 2008/01/09 received; 2008/05/17 revised; 2008/06/18 accepted; ppublish;.
M. Blanda, L. Gerson, and K. Dunn. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 6 (4):
286-91(April 1999)5804<m:linebreak></m:linebreak>LR: 20041117; JID: 9418450; ppublish;<m:linebreak></m:linebreak>Recursos/Organització; Formació.
B. Miladinovic, A. Kumar, R. Mhaskar, S. Kim, R. Schonwetter, and B. Djulbegovic. PloS one, 7 (10):
e47804(January 2012)6965<m:linebreak></m:linebreak>JID: 101285081; 2012/05/11 received; 2012/09/21 accepted; 2012/10/17 epublish; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Avaluació de riscs.